Why One Fund Owns 13% of This Small-Cap Pharma
Source: Streetwise Reports  (12/12/22)
Clinical-stage Algernon Pharmaceuticals' multiple pipelines include testing a psychedelic for the treatment of stroke, and testing other drugs for idiopathic pulmonary fibrosis and chronic kidney disease.
More >

Expert Says Silver May Have a 'Stellar Performance in 2023'
Source: Michael Ballnger  (12/12/22)
Expert Michael Ballanger revisits silver as both a monetary and industrial commodity to tell you where he believes the metal is headed. More >

Gold Co.'s Early Drilling Intersects High-Grade Gold
Source: Streetwise Reports  (12/12/22)
This morning, McFarlane Lake Mining Ltd. announced new drill results at its High Lake property in Ontario. Read more to see the results and view what experts are saying. More >

Expert Says Gold Is Misunderstood, but It Is Bottoming
Source: Adrian Day  (12/12/22)
Expert Adrian Day takes a look at gold and discusses why he thinks a turn is very close. Day also recommends his top stocks to buy if you do not already own. More >

Counter-Drone Co. Receives DOD Recommendation and AU$3.7M Private Placement
Source: Streetwise Reports  (12/9/22)
With the need for counterdrone technologies rising, Australian and U.S.-based DroneShield Ltd. has released a lot of news. Read more to learn about the company's myriad of orders, the DOD recommendation, and the recent million-dollar placement. More >

Copper Junior Likes Early Results at B.C. Projects
Source: Streetwise Reports  (12/9/22)
Junior explorer Alpha Copper Corp. is finishing drilling at two of its British Columbia projects but already likes the mineralization it has seen on the sites. More >

'Amazing' Drill Results Point to Big Opportunity, Analyst Says
Source: Streetwise Reports  (12/9/22)
Junior explorer Western Exploration Inc. releases more "amazing" drill results from its Aura gold project in northern Nevada, one investment manager says. More >

Silver Producer Yields Record Revenue in Q3/22
Source: Timothy Lee   (12/9/22)
The company grew revenue 73% from Q2/22 while continuing to ramp-up production at its cornerstone Peruvian mining asset, noted a Red Cloud Securities report. More >

Biotech Co. Signs US$735M Deal
Source: Streetwise Reports  (12/9/22)
Entrada Therapeutics Inc. shares traded 18.5% higher yesterday after the company reported it entered a global development collaboration with Vertex Pharmaceuticals Inc. to develop cutting-edge intracellular Endosomal Escape Vehicle (EEVâ„¢) therapeutics for use in treating myotonic dystrophy type 1. More >

Expert Says Gold Co. Is 'Most Attractive'
Source: Clive Maund  (12/8/22)
Expert Clive Maund takes a look at NevGold Corp.'s 6-month and 18-month charts to tell you why he believes it is most attractive now. More >

Drilling Confirms S.D. Land Contains Sulphide Gold System
Source: Michael Fairbairn  (12/8/22)
The company is drilling, too, to test its hypothesis that the property also contains the type of gold mineralization associated with the historical Homestake mine, noted a Canaccord Genuity report. More >

Analyst: Timing Perfect for Nevada Lithium Project
Source: Streetwise Reports  (12/7/22)
Rover Metals Corp. is making the jump from gold to lithium and critical elements. One analyst said the timing is perfect. More >

Biopharma Co.'s Shares Triple in Value on US$5B License Deal
Source: Streetwise Reports  (12/7/22)
Summit Therapeutics Inc. shares traded 194% higher yesterday after the company reported it entered into an in-license agreement with Akeso Inc. for its breakthrough bispecific antibody ivonescimab, which combines a blockade of PD-1 with an anti-VEGF into a single molecule designed to target cancer. Summit has agreed to pay Akeso an upfront payment of US$500 million, which it plans to finance via an equity rights issuance. More >

Resource Co. Completes 2022 Drilling and Receives US$895 Million
Source: Streetwise Reports  (12/7/22)
Canadian-based Skyharbour Resources has announced it plans to complete a 10,000m drill program at its Russell Lake property. It has also recently received US$895 million from the exercise of share purchase warrants. Read here to learn more about the project and where the company is headed for 2023. More >

Biotech Co.'s Shares Soar to New 52-Week High
Source: Streetwise Reports  (12/7/22)
Prometheus Biosciences Inc. shares traded 170% higher to a new 52-week intraday high after the company reported positive results from two separate Phase 2 clinical studies for its PRA023, an anti-TL1A mAb used to treat inflammatory bowel disease. The company is actively planning to advance PRA023 into Phase 3 trials as a prospective treatment for ulcerative colitis and Crohn's disease in FY/23. More >

Exploration Project on Track To Reach Milestones in 2023
Source: Varun Arora  (12/7/22)
"Significant" news flow from the Spanish polymetallic property should lead to a "strong rerating" of the company, noted a Clarus Securities report. More >

Silver Explorer Seeing Results in Golden Triangle
Source: Streetwise Reports  (12/6/22)
Dolly Varden Silver Corp. is taking stock of more than 37,000m drilled in 108 holes at its massive Dolly Varden and Homestake Ridge projects in British Columbia. More >

Resources Co. Has 'Significant Fundamental Value' Despite Outstanding Trial
Source: Adam Schatzker  (12/5/22)
Uncertainty about this Spanish asset remains, but the Canadian explorer has other projects in the country providing value and upside, noted a Research Capital Corp. report. More >

A Slumbering Inflation Hedge at Slave Lake
Source: Streetwise Reports  (12/5/22)
With inflation on the rise, investor attention has shifted to more tangible assets such as zinc-lead. With a positive relationship with locals and good ESG, Slave Lake Zinc Corp. may be one company you want to add to your radar. More >

Rare Earths Co. Drills Deepest Hole Yet in B.C.
Source: Streetwise Reports  (12/5/22)
Defense Metals Corp. has now released results from 10 of 18 holes in its 5,500m drill program this year. More >

Co. Addresses Infrastructure at Idaho Gold Project
Source: Geordie Mark  (12/5/22)
Two recent events help the firm in its efforts to secure water and power access for a future mining operation there, noted a Haywood Securities report. More >

Analyst Says Now Is the Time To Invest in This B.C. Silver Co.
Source: Streetwise Reports  (12/5/22)
Accumulating a myriad of analyst coverage, Dolly Varden Silver Corp. has been on our radar for a while, and with its latest drill results, now may be the time to invest, according to a Haywood Capital report. More >

Co. Reports Positive Results in Phase 2b/3 Alzheimer's Trial
Source: Streetwise Reports  (12/5/22)
Shares of Anavex Life Sciences Corp. traded 36% higher Friday after the company reported that during a Phase 2b/3 clinical trial of patients diagnosed with early Alzheimer's disease, its ANAVEX®2-73 (blarcamesine) met both key primary and secondary endpoints and demonstrated significant reductions in clinical decline. More >

Welcome to the New Golden Bull
Source: Michael Ballanger  (12/5/22)
Expert Michael Ballanger of GGM Advisory Inc. reviews Andrew Ross Sorkin's decision to interview SBF in a global broadcast, Fed Chairman Jerome Powell's November 30th email alert, and the price of gold as it advances to tell you where he believes the market is heading and what you should look out for. More >

First Drill Results are 'Compelling,' High Grade
Source: Stuart McDougall  (12/2/22)
One hole at this British Columbia property returned 75.13 grams per ton gold and 2,337 grams per ton silver over 1.77 meters, noted a Research Capital Corp. report. More >